ERC funding at KI

Denna sida på svenska

The main goal of the European Research Council (ERC) is to encourage high quality research in Europe through competitive funding.

ERC Advanced Grants

ERC Advanced Grants, worth up to 3.5 mEuro, allow exceptional established research leaders of any nationality and any age to pursue ground-breaking, high-risk projects that open new directions in their respective research fields or other domains. The ERC Advanced Grant funding targets researchers who have already established themselves as independent research leaders in their own right. At KI the following researchers have received an ERC Advanced Grants:

2015

  • Jonas Frisén (second grant) – Exploration and promotion of neurogenesis in the adult brain
  • Thomas Helleday – Targeting oxidative repair proteins for treatment of cancer and inflammation
  • Ole Kiehn (second grant) – Functional deciphering of the integrated brainstem connectome that selects locomotor behavior
  • Klas Wiman – Restoration of tumor suppressor function by induction of translational read-through of premature termination codons - a strategy for improved cancer therapy

2013

  • Per-Olof Berggren – An in vivo imaging approach to understand pancreatic beta-cell signal-transduction
  • Carlos Ibanez (second grant) – Understanding death-receptor signaling and physiology in the nervous system

2012

  • Christer Betsholtz – Mechanisms of regulation of the blood-brain barrier
  • Lars Olson – Plasticity and formation of lasting memories in health and disease

2011

  • Thomas Helleday – GEnetic NEtworks as a tool for anti-CAncer Drug Development

2010

  • Jonas Frisén – Neurogenesis in the adult human brain
  • Ole Kiehn – Linking glutamatergic spinal cord and brainstem neuronal circuits to the control of locomotor behavior
  • Thomas Helleday – GEnetic NEtworks as a tool for anti-CAncer Drug Development

2009

  • Lars Klareskog – Genes, environment and immunity in the pathogenesis of rheumatoid arthritis
  • Yihai Cao – New mechanisms of angiogenesis modulators in switching between white and brown tissue

2008

  • Patrik Ernfors – Identification of new mechanism of stem cell self-renewal
  • Carlos Ibanez – Metabolic control by the TGF-x superfamilt receptor ALK7
  • Jussi Taipale – Dissecting the transcriptional mechanisms controlling growth during normal development and cancer
  • Juleen Zierath – Discovery of type 2 diabetes targets

ERC Consolidator Grants

ERC Consolidator Grants, worth up to 2 mEuro, are designed to support researchers at the stage at which they are consolidating their own independent research team or programme. The scheme will strengthen independent and excellent new individual research teams that have been recently created. At KI the following researchers have received an ERC Consolidator Grant:

2016

  • Björn Högberg – Cellular Position Tracking Using DNA Origami Barcodes (CellTrack)

2015

  • Gonçalo Castelo-Branco – Reversing the epigenetic state of oligodendrocyte precursors cells in multiple sclerosis (EPIScOPE )
  • Weimin Ye – Understanding microbe-induced stomach cancer; the key to a workable strategy for worldwide prevention

2014

  • Rickard Sandberg – Revealing allele-level regulation and dynamics using single-cell gene expression analyses
  • Per Svenningsson – Prosaposin and GPR37 in synucleinopathies

2013

ERC Starting Grants

ERC Starting Grants, worth up to 2 mEuro, aim to support up-and-coming research leaders who are about to establish a proper research team and to start conducting independent research in Europe. The scheme targets promising researchers who have the proven potential of becoming independent research leaders. It will support the creation of excellent new research teams. At KI the following researchers have received an ERC Starting Grant:

2016

  • Magda Bienko – Illuminating GENome Organization through integrated MIcroscopy and Sequencing
  • Simon Elsässer – Chromatin dynamics resolved by rapid protein labeling and bioorthogonal capture
  • Anna Wredenberg – Mitochondrial methylation and its role in health and disease

2015

  • Petter Brodin - Shaping of the human immune system by primal environmental exposures in the newborn child 
  • Lars Maegdefessel - Therapeutic and biomarker potential of long non-coding RNAs in vascular disease

2013

  • Marie Carlén – The role of parvalbumin in interneurons in cognition and behaviour
  • Erik Ingelsson (now at Uppsala university)

2012

  • Pontus Boström – Irisin - a novel myokine protective against metabolic disease
  • Yenan Bryceson – Next generation sequencing for detection of human primary immunodeficiency syndromes
  • Christian Göritz – The role of pericytes in central nervous system scarring and fibrosis
  • Kristian Pietras – Exploring the tumor as a communicating organ
  • Tomas Renné – Factor XII and the contact system: cross-talk between thrombosis and inflammation 

2011

2010

2009

  • Qiang Pan-Hammarström – Switch recombination: A model for DNA editing and repair in human lymphocytes
  • Rickard Sandberg – Single-cell gene regulation in differentiation and pluripotency

2007

ERC Proof of Concept

The ERC launched the new funding initiative, called "Proof of Concept", in March 2011, open to researchers who have already been awarded an ERC grant. The grant is worth up to 150.000 Euro. ERC grant holders can apply for this additional funding to establish the innovation potential of ideas arising from their ERC-funded frontier research projects. At KI the following researchers have received an ERC Consolidator Grant:

2016

  • Per-Olof Berggren – Validation of an in vivo translational medicine approach for the treatment of diabetes and diabetes complications

​2015

  • Thomas Helleday – Commercializing first-in-class dCTPase Inhibitors for treatment of hematological Cancers

2014

  • Patrik Ernfors – Validation of a conceptually new treatment for glioblastoma multiforme

2013

  • Thomas Helleday – Proof of concept use of MTH1 inhibitors as new treatments for cancer

2012

Links

FundingGrantInternational